Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Trends in Endocrinology and Metabolism: TEM|August 27, 2024
Patient-derived organoid models to decode liver pathophysiologyBenjamin J Dwyer, Janina E E Tirnitz-ParkerJournal of Hepatology|September 25, 2020
Cell therapy for advanced liver diseases: Repair or rebuildBenjamin J Dwyer, Mark T Macmillan, Paul N Brennan, et al.Frontiers in Immunology|March 5, 2014
TWEAK and LTβ Signaling during Chronic Liver DiseaseBenjamin J Dwyer, John K Olynyk, Grant A Ramm, et al.International Journal of Molecular Sciences|January 31, 2017
Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic SyndromeSalamah M Alwahsh, Benjamin J Dwyer, Shareen Forbes, et al.NPJ Regenerative Medicine|January 6, 2018
Raman spectroscopy and regenerative medicine: a reviewKatherine J I Ember, Marieke A Hoeve, Sarah L McAughtrie, et al.Journal of Inflammation (London, England)|March 21, 2025
Semaphorin 7a is protective through immune modulation during acetaminophen-induced liver injuryEilidh J Livingstone, Jennifer A Cartwright, Lara Campana, et al.The American Journal of Pathology|May 17, 2016
Divergent Inflammatory, Fibrogenic, and Liver Progenitor Cell Dynamics in Two Common Mouse Models of Chronic Liver InjuryJulia Köhn-Gaone, Benjamin J Dwyer, Candice A Grzelak, et al.Cytotherapy|July 5, 2017
Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosisAlasdair R Fraser, Chloe Pass, Paul Burgoyne, et al.Nature|July 13, 2017
Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regenerationAlexander Raven, Wei-Yu Lu, Tak Yung Man, et al.Nature|March 16, 2018
Corrigendum: Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regenerationAlexander Raven, Wei-Yu Lu, Tak Yung Man, et al.Pageof 2